CryoPort Continues Strong Market Development with Tradeshow and Conference Participation in October and November
SAN DIEGO--(BUSINESS WIRE)-- CryoPort, Inc. (OTCBB: CYRX) today announced its participation in four life science and logistics management industry conferences from mid-October through early November, with each providing an opportunity to meet potential customers and present the advantages of the CryoPort solution. These conferences are in addition to the five U.S. and international events at which the Company presented in September and early October.
“The management of deep frozen shipping is an increasingly important issue in the life science industry, and we received strong attention and very positive feedback during recent conferences in Berlin, Dubai, Singapore, Boston and Philadelphia,” said Larry Stambaugh, CryoPort’s chairman and chief executive officer. “These four additional conferences continue our aggressive marketing and business development effort, which we believe will drive additional trial and eventual adoption of our unique dry shipper and superior logistics solution.”
Additional information on each of the conferences described below can be found at: http://www.cryoport.com/our-company/news-events/upcoming-events/
- CryoPort’s senior sales director for Europe, Upinder Grewal, attended the 6th Annual Temperature Controlled Pharmaceutical Distribution Conference in Switzerland on October 11-12, 2011. This event was attended by professionals involved with the transportation, logistics, storage and packaging of ambient and temperature sensitive pharma and biopharmaceutical products, and was focused on helping those professionals uncover the best practices for temperature controlled pharmaceutical distribution to ensure that products arrive in pristine condition.
- CryoPort is exhibiting at the 2011 American Society for Reproductive Medicine Conference at the Orlando Convention Center in Orlando on October 15 -19. The Company has received significant interest from in vitro fertilization clinics, and this conference is attended by the practitioners and organizations that are helping to set the standards in this profession.
- CryoPort vice president & chief commercial officer Mark Engelhart and senior sales director Tim McClatchy will be attending the 2011 NIH Research Festival in Bethesda, Maryland, October 27-28. During this conference more than 400 exhibitors will display state-of-the-art equipment, supplies and services by leading regional and national biomedical research suppliers.
- Mr. Stambaugh will be presenting, and Mr. Engelhart will be on a panel at the 2011 Clinical Trials Supply and Logistics Summit at the Omni Hotel in San Diego, November 7-9. The conference is focused on ensuring quality, compliance and efficiency in conducting clinical trials, including the transportation of biologic material.
About CryoPort, Inc.
CryoPort (www.cryoport.com) provides leading edge cold chain logistics services through the combination of purpose built proprietary technologies and total turnkey management of the entire process. CryoPort’s CryoPort Express liquid nitrogen based dry vapor shipper is validated to maintain a constant -150 C temperature for a minimum 10 day dynamic shipment duration, and its CryoPortal Logistics Management Platform manages the entire shipment process, including initial order, document preparation, customs clearance, courier management, shipment tracking, issue resolution,and delivery. CryoPort’s total turnkey service management approach offers total reliability, cost effectiveness, and convenience, while the use of recyclable and reuseable components provides a totally “green” and environmentally friendly solution. For more information visit www.cryoport.com and the Cold Chain Transport blog at http://www.cryoport.com/biological-shipping-blog/
LHA
Don Markley, 310-691-7100
dmarkley@lhai.com
Source: CryoPort, Inc.
Released October 18, 2011